Allied Corp.

OTC: ALID · Healthcare · Drug Manufacturers - Specialty & Generic

Canadian filerHQ Kelowna, BCCIK 0001575295Reports USD

#1031 of 1,394 Healthcare companies by revenue73rd-percentile growth

EA Score

——

FH —DQ 23GM —SS 40

v0.1 · 25/100 weight · pillars only

↑ 3-yr revenue growth, revenue growth (YoY) · ↓ growth stability, operating margin

Methodology →

Revenue TTM

$72.1k

Rev growth YoY (TTM)

-53.9%

Net income (FY)

-$4.0M

Employees

150

Market cap

$57.7k

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Revenue$96.2k$96.2k2024

Net income-$4.0M-$4.0M2024

Operating income-$4.0M-$4.0M2024

Total assets$2.1M$2.1M2024

Liabilities$9.7M$9.7M2024

Equity-$7.5M-$7.5M2024

Revenue trend

FY2020 – FY2024 · USD

FY20

$12.5k

FY21

$165.6k

FY22

$72.1k

FY23

$96.2k

FY24

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

Allied Corp. booked $96.2k in FY2024 revenue, growing 33% year over year — faster than most Healthcare companies we track, at a -4134.1% net margin.

Peers · Healthcare

Psyence Biomedical Ltd.——Endexx Corporation——Cannabis Global Inc.——Biome Grow Inc.——

Key facts

CEOMichael Moses

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

HeadquartersKelowna, BC

ExchangeOTC: ALID

Employees150

IPO date2019-08-15

Latest filings

8-K2025-02-05 8-K2025-01-22 10-Q2025-01-14 10-K2024-12-16 8-K2024-11-18 8-K2024-10-15 8-K2024-09-24 8-K2024-09-13

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.